Breast Cancer Deadlier for Black Women, Despite Same Treatments
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Obesity May Be Driving Rise in Uterine Cancers
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Breast Cancer Deadlier for Black Women, Despite Same Treatments
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

100,000 whole genomes sequenced in the NHS
The 100,000 Genomes Project has sequenced 100,000 whole genomes, helping to improve diagnosis and treatment for patients with rare diseases and cancer. (Source: NHS Networks)
Source: NHS Networks - December 6, 2018 Category: UK Health Source Type: news

Fewer Early Stage Breast Cancer Patients May Need Lymph Node Removal: Study
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: Poll
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Tamoxifen at a Lower Dose Might Still Prevent Breast Cancer's Return
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Fewer Early Stage Breast Cancer Patients May Need Lymph Node Removal: Study
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Tamoxifen at a Lower Dose Might Still Prevent Breast Cancer's Return
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

This test can spot all types of cancers in 10 min
It involves taking blood sample of the patient and examining the pattern of molecules called methyl groups that decorate its DNA. (Source: The Economic Times)
Source: The Economic Times - December 6, 2018 Category: Consumer Health News Source Type: news

Alberta boy with thyroid cancer runs, plays after taking U.S.-approved drug
This winter, Kayley Leeds can watch her nine-year-old ski and run around with his siblings, but a year and a half ago, her little boy was more likely to be in bed. A new cancer drug, recently approved in the United States, has changed her family's life. (Source: CBC | Health)
Source: CBC | Health - December 5, 2018 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger
OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday. The reverse merger between Redwood City-based OncoMed and Mereo BioPharma Grou p plc will give the London company a U.S. stock listing and seven experimental drugs. If the deal closes as expected in first-half 2019, it would close the books on OncoMed… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 5, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger
OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday. The reverse merger between Redwood City-based OncoMed and Mereo BioPharma Grou p plc will give the London company a U.S. stock listing and seven experimental drugs. If the deal closes as expected in first-half 2019, it would close the books on OncoMed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 5, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

AbbVie halts late-stage trial for lung cancer drug Rova-T
AbbVie said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung cancer, following recommendations made by an independent data monitoring committee. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA gives Roche immunotherapy drug priority review
The FDA has awarded Roche an accelerated review of its immunotherapy drug, Tecentriq, to treat non small-cell lung cancer. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 5, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: PSA levels after prostatectomy
A prostatectomy is one treatment option for prostate cancer. It involves the surgical removal of the prostate gland. Following a prostatectomy, doctors carry out regular prostate-specific antigen (PSA) testing to check that the cancer is not returning. Learn more about PSA after a prostatectomy here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Ask the Doctors: How gut microbiome affects cancer treatment
According to Dr. Eve Glazier, the patients who responded best to treatment with a certain class of immunotherapy drugs were those with the more diverse and robust gut microbiomes.12/05/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - December 5, 2018 Category: Urology & Nephrology Source Type: news

miR ‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3
MicroRNAs (miRNAs) serve an important role in renal cancer, but renal cancer miRNA expression data remains inconsistent.12/05/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - December 5, 2018 Category: Urology & Nephrology Source Type: news

Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience
Sunitinib treatment has acceptable efficacy and safety profile in Malaysian mRCC patients. The MSKCC and IMDC factors are relevant for predicting survival in our patient cohort while HFS is a promising prognostic predictor which warrants further investigation.12/05/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - December 5, 2018 Category: Urology & Nephrology Source Type: news

Tiny Wearable Device Warns of Exposure to UV Light
Northwestern Medicine and Northwestern’s McCormick School of Engineering scientists have developed what is being called the world’s smallest wearable, battery-free device to measure light. The technology enables scientists to measure exposure to light across multiple wavelengths. The device is as about as thick in diameter as a credit card and is about the size of an M&M. It is also solar powered. Researchers said the device monitored therapeutic UV light in clinical phototherapy booths for psoriasis and atopic dermatitis as well as blue light phototherapy for newborns with jaundice ...
Source: MDDI - December 5, 2018 Category: Medical Devices Authors: Omar Ford Tags: Electronics Source Type: news

GRAIL ’s SUMMIT Will Help Define its Liquid Biopsy Path
A long-awaited and massive study with major implications for the liquid biopsy market is slated to start next year. Earlier this week, GRAIL revealed that it would initiate its 50,000-patient SUMMIT study in early 2019. Ages of the patients will be men and women between the ages of 50 and 77 who do not have a cancer diagnosis at the time of enrollment. The Menlo Park, CA-based company gave more specifics of the trial and said half the participants will be people at high risk for lung and other cancers due to a significant smoking history, and the other half will be people who are not at high risk for cancer based on smokin...
Source: MDDI - December 5, 2018 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

New Standard When HER2+ Breast Cancer Isn't Cleared New Standard When HER2+ Breast Cancer Isn't Cleared
' Practice-changing'results support adjuvant trastuzumab emtansine in patients with HER2+ early stage breast cancer who have residual disease following surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 5, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Lung cancer symptoms: Eight signs not usually associated with the deadly disease
LUNG cancer symptoms can easily mistaken for less serious health conditions, which is why the disease often isn ’t diagnosed until it’s reached later stages. Here are seven signs often overlooked or ignored. (Source: Daily Express - Health)
Source: Daily Express - Health - December 5, 2018 Category: Consumer Health News Source Type: news

Researchers create sensors to measures cancer's ability to spread, study says
Researchers from the University of California, San Diego say they have developed a method to detect and measure cancer as it spreads throughout the body. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 5, 2018 Category: Consumer Health News Source Type: news

Mylan recalls blood pressure drug over cancer concern
Prescription drugs sold nationwide may contain trace amounts of probable carcinogen also found in tobacco smoke (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 5, 2018 Category: Consumer Health News Source Type: news

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men
WEDNESDAY, Dec. 5, 2018 -- Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the British Journal of Cancer. Yanan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2018 Category: Pharmaceuticals Source Type: news

SABCS: Delaying Chemo Lowers Survival in Triple-Neg Breast CA
WEDNESDAY, Dec. 5, 2018 -- Delaying initiation of adjuvant chemotherapy in triple-negative breast cancer (TNBC) patients more than 30 days after surgery is associated with a decrease in survival, according to a study presented at the annual San... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: Can drinking alcohol lead to prostate cancer?
Doctors do not fully understand what causes prostate cancer. This disease may have an association with alcohol, but scientists need to do more research to confirm the potential link. Here, learn more about the risks of alcohol, how doctors screen for and treat prostate cancer, and the survival rates for this disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Talcum powder may be associated with respiratory illness and possibly ovarian cancer, Health Canada warns
Don't inhale talcum powder and keep it away from children's faces and female genitals, Canada's health and environment agencies advised on Wednesday. (Source: CBC | Health)
Source: CBC | Health - December 5, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Newly identified T cells could play a role in cancer and other diseases
FINDINGSResearchers from the UCLA Jonsson Comprehensive Cancer Center and the La Jolla Institute for Immunology have identified a new type of T cell called a phospholipid-reactive T cell that is able to recognize phospholipids, the molecules that help form cells ’ outer membranes.The scientists also discovered that phospholipids compete with glycolipids, another type of molecule that helps form cells ’ outer membranes, in a way that prevents glycolipids from readily reaching the surface of a cell.BACKGROUNDCell membranes are primarily made up of two types of lipids — phospholipids and glycolipids. Inside ...
Source: UCLA Newsroom: Health Sciences - December 5, 2018 Category: Universities & Medical Training Source Type: news

Rapid Test for Cancer Developed by Researchers
The team at the University of Queensland in Australia created the test after discovering that cancer forms a unique DNA structure when placed in water, CNN reported. (Source: WebMD Health)
Source: WebMD Health - December 5, 2018 Category: Consumer Health News Source Type: news

Cancer-VTE Trial Falls Short
(MedPage Today) -- High dropout rate undermines rivaroxaban prophylaxis trial (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 5, 2018 Category: Cardiology Source Type: news

ASH: Rivaroxaban Prevents Blood Clots in At - Risk Cancer Patients
Risk for patients in rivaroxaban group reduced during the on - treatment period (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 5, 2018 Category: Cancer & Oncology Tags: Cardiology, Oncology, Pharmacy, Conference News, Source Type: news

Lung cancer symptoms: Eight signs of the disease that are often ignored
LUNG cancer symptoms can easily mistaken for less serious health conditions, which is why the disease often isn ’t diagnosed until it’s reached later stages. Here are seven signs often overlooked or ignored. (Source: Daily Express - Health)
Source: Daily Express - Health - December 5, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Universal 10-minute cancer test in sight
Cancer cells have a unique pattern of chemical tags on their DNA, which differs from that of healthy cells and could serve as the basis for a universal test. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

From Patent to Patient: our report analysing access to innovative cancer drugs
This report highlights the progress that is being made with discovering new cancer medicines and draws attention to key challenges that will need to be overcome to ensure more patients can benefit from these advances. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 5, 2018 Category: Consumer Health News Source Type: news

Too Much Sleep Linked To Greater Risk Of Disease & Death, Study Finds
(CNN) — The recommended amount of sleep for adults is six to eight hours a night. Sleeping more than those hours is associated with an increased risk of death and cardiovascular diseases, says a global study published Wednesday in the European Heart Journal. Looking at data from 21 countries, across seven regions, the research team found that people sleeping more than the recommended upper limit of eight hours increased their risk of major cardiovascular events, like stroke or heart failure, as well as death by up to 41%. But a possible reason for this could be that people have underlying conditions causing them to s...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 5, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Sleep Source Type: news

The Future Of Cancer Care: A 50 Minute Discussion At Forbes
The future of cancer therapy, an analysis of how Immunotherapy has improved oncology outcomes for patients. This year's Forbes Summit highlighted both the difficulties, advancements and needs of the cancer care community in order to find the " cure " for cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 5, 2018 Category: Pharmaceuticals Authors: Steve Brozak, Contributor Tags: NYSE:MRK NASDAQ:LOXO NASDAQ:ALLO Source Type: news

Cancer services profiles: 2018 annual update
This new profile tool brings together a selection of mortality indicators from other PHE data tools, making it easier to assess outcomes across a range of causes of death. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 5, 2018 Category: Consumer Health News Source Type: news

Worldwide hunt for rare blood to help Miami girl fight cancer
The 2-year-old with some of the rarest blood in the world who is also battling a very aggressive form of cancer (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 5, 2018 Category: Consumer Health News Source Type: news

Can Anthracyclines be Excluded From Neoadjuvant HER2+ Breast Cancer Tx?
A comparison of chemotherapy regimens plus anti-HER2 therapy in the neoadjuvant setting tested whether the addition of anthracyclines is necessary for patients with HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - December 5, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Varian Halcyon Treatment System Receives China NMPA Approval
To view this release online and get more information about Varian visit: www.varian.com/newsroom PALO ALTO, Calif., Nov. 28, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced its Halcyon™ system has been approved by the China National Medical Product Administration (NMPA), which allows the company to market this new cancer treatment system in China.  This approval further expands the global availability of Halcyon and access to high-quality, cost-effective cancer...This story is related to the following:Radiotherapy Systems (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - December 5, 2018 Category: Medical Devices Source Type: news

Drug Halves Recurrence for Common Breast Cancer
All of the women in the new trial had undergone a standard treatment scenario. First, they received traditional chemotherapy and the drug Herceptin (trastuzumab) -- an antibody that targets HER2-positive cancer cells. Then they had surgery to remove any remaining cancer. (Source: WebMD Health)
Source: WebMD Health - December 5, 2018 Category: Consumer Health News Source Type: news

Too Much Time in the Sun? Skin Patch Might Tell
WEDNESDAY, Dec. 5, 2018 -- A new mint-sized, battery-free patch that alerts wearers to potentially harmful sunlight exposure in real time might become a powerful weapon in preventing skin cancer. Powered by the sun while designed to measure its... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2018 Category: General Medicine Source Type: news

Roche ’s Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced that the phase III KATHERINE study met its primary endpoint, showing Kadcyla ® (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death (invasive disease-free survival; iDFS) by 50% (HR=0.50, 95% CI 0.39-0.64, p (Source: Roche Investor Update)
Source: Roche Investor Update - December 5, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced that the phase III KATHERINE study met its primary endpoint, showing Kadcyla ® (trastuzumab emtansine) as a single agent significantly reduced the risk of disease recurrence or death (invasive disease-free survival; iDFS) by 50% (HR=0.50, 95% CI 0.39-0.64, p (Source: Roche Media News)
Source: Roche Media News - December 5, 2018 Category: Pharmaceuticals Source Type: news

ASH: Rivaroxaban Prevents Blood Clots in At-Risk Cancer Patients
WEDNESDAY, Dec. 5, 2018 -- Rivaroxaban can prevent venous thromboembolism (VTE) in cancer patients at increased risk, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 1 to 4 in San... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2018 Category: Pharmaceuticals Source Type: news

10-minute cancer test detects cancer anywhere in the body, new study says
Researchers in Australia have developed a 10-minute test that can detect the presence of cancer cells anywhere in the human body, according to a newly published study. (Source: CNN.com - Health)
Source: CNN.com - Health - December 5, 2018 Category: Consumer Health News Source Type: news

How we improved end-of-life care in our practice
Dr Victoria Middleton explains how her practice has increased the number of patients on its palliative care register, reduced avoidable hospital admissions and increased the number of people able to die at home by a third. (Source: GP Online Education)
Source: GP Online Education - December 5, 2018 Category: Primary Care Tags: 12 Care of People with Cancer and Palliative Care Source Type: news

Cochrane Library Special Collection: Diagnosing skin cancer
ThisSpecial Collection of Cochrane Systematic Reviews brings together a large body of research on the accuracy of tests used to diagnose skin cancer.The suite of eleven reviews was  led by Dr Jac Dinnes at the University of Birmingham and supported by theCochrane Skin Group and a team of over 30 researchers and expert advisors, funded by the  National Institute for Health Research (NIHR).   The reviews  summarise research evidence assessing the accuracy of different diagnostic tests to support clinical and policy related decision making in the diagnosis of all types of skin cancer. D...
Source: Cochrane News and Events - December 5, 2018 Category: Information Technology Authors: Katie Abbotts Source Type: news